(Q35164781)

6 August 2017

1 reference

title

Progress and challenges for cell encapsulation in brain tumour therapy (English)

1 reference

6 August 2017

Therese Visted

1

1 reference

6 August 2017

Morten Lund-Johansen

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Expert Opinion on Biological Therapy

6 August 2017

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

551-561

1 reference

Analysis of p53 tumor suppressor gene in families with multiple glioma patients.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Survival in glioblastoma: historical perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Microencapsulated islets as bioartificial endocrine pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Cell encapsulation: promise and progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Microcapsules made by enzymatically tailored alginate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Improvement of the biocompatibility of alginate/poly-L-lysine/alginate microcapsules by the use of epimerized alginate as a coating

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Improving cell encapsulation through size control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Angiogenesis and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Local endostatin treatment of gliomas administered by microencapsulated producer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Continuous release of endostatin from microencapsulated engineered cells for tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Alginate type and RGD density control myoblast phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

A novel approach to tumor suppression with microencapsulated recombinant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Unique Aspects of Central Nervous System Immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Nervous tissue as an immune compartment: the dialect of the immune response in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Grafting of encapsulated BDNF-producing fibroblasts into the injured spinal cord without immune suppression in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Encapsulated genetically engineered fibroblasts: release of nerve growth factor and effects in vivo on recovery of cholinergic markers after devascularizing cortical lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Initial sequencing and analysis of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Artificial cells with emphasis on cell encapsulation of genetically engineered cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Delivery of recombinant product from subcutaneous implants of encapsulated recombinant cells in canines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Polymer-encapsulated genetically modified cells continue to secrete human nerve growth factor for over one year in rat ventricles: behavioral and anatomical consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.4.551

21 January 2018

Identifiers

DOI

10.1517/14712598.3.4.551

1 reference

6 August 2017

1 reference